{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:30:38Z","timestamp":1782894638594,"version":"3.54.5"},"reference-count":0,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Exp Immunol"],"DOI":"10.62347\/bnnl4902","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:28:53Z","timestamp":1782887333000},"page":"193-202","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cannabinoid receptor 1 for multiple sclerosis: molecular docking and dynamic insights of berberine and curcumin as potential therapeutic agents"],"prefix":"10.62347","volume":"15","author":[{"given":"Jehan","family":"Alrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"container-title":["American Journal of Clinical and Experimental Immunology"],"original-title":[],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:28:54Z","timestamp":1782887334000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcei\/15\/3\/ajcei0167838.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/bnnl4902","relation":{},"ISSN":["2164-7712"],"issn-type":[{"value":"2164-7712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}